Sample size recommendation for a bioequivalent study
From MaRDI portal
Publication:4965778
DOI10.6092/ISSN.1973-2201/6699zbMATH Open1454.62310OpenAlexW2606926532MaRDI QIDQ4965778FDOQ4965778
Authors: Chandrasekhar Bhupathi, Venakata Haragopal Vajjha
Publication date: 10 March 2021
Full work available at URL: https://ideas.repec.org/a/bot/rivsta/v77y2017i1p65-71.html
Recommendations
- A Simple Formula for Sample Size Calculation in Equivalence Studies
- Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework
- Determining average bioequivalence and corresponding sample sizes in general asymmetric settings
- Determining equivalence and the impact of sample size in anti-infective studies: a point to consider
- A More Powerful Average Bioequivalence Analysis for the 2 × 2 Crossover
Cites Work
- Title not available (Why is that?)
- First passage percolation on random graphs with finite mean degrees
- A general sequential fixed-accuracy confidence interval estimation methodology for a positive parameter: illustrations using health and safety data
- On MP test and the MVUEs in a \(N(\theta, c\theta)\) distribution with \(\theta\) unknown: illustrations and applications
- Applications of Sequentially Estimating the Mean in a Normal Distribution Having Equal Mean and Variance
- Theory and applications of a new methodology for the random sequential probability ratio test
- A Note on Minimum Variance Unbiased Estimation
This page was built for publication: Sample size recommendation for a bioequivalent study
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4965778)